60
Participants
Start Date
April 1, 2021
Primary Completion Date
January 30, 2023
Study Completion Date
January 30, 2023
Drug: Bupivacaine 0.375% 20 mL
20 mL 0.375% Bupivacaine
Drug: Bupivacaine 0.375% diluted to 0.1875%
Each block of 0.375% Bupivacaine x 20 ml mixed (diluted) with Normal Saline Solution 20 mL (total 40 mL)
University of pittsburgh, Pittsburgh
UPMC shadyside hospital, Pittsburgh
Anna Uskova
OTHER